EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential

Oveena Fonseka, Sanskruti Ravindra Gare iD, Xinyi Chen, Jiayan Zhang, Nasser Hawimel Alatawi, Claire Ross, Wei Liu

Cells · 20.02.2025 · 14 (5) · 324

DOI: 10.3390/cells14050324 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 20.02.2025. Verfasst von Oveena Fonseka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, UK. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 511 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is a prominent fatal cardiovascular disorder afflicting 3.4% of the adult population despite the advancement of treatment options. Therefore, a better understanding of the pathogenesis of HF is essential for exploring novel therapeutic strategies. Hypertrophy and fibrosis are significant characteristics of pathological cardiac remodeling, contributing to HF. The mechanisms involved in the development of cardiac remodeling and consequent HF are multifactorial, and in this review, the key underlying mechanisms are discussed. These have been divided into the following categories thusly: (i) mitochondrial dysfunction, including defective dynamics, energy production, and oxidative stress; (ii) cardiac lipotoxicity; (iii) maladaptive endoplasmic reticulum (ER) stress; (iv) impaired autophagy; (v) cardiac inflammatory responses; (vi) programmed cell death, including apoptosis, pyroptosis, and ferroptosis; (vii) endothelial dysfunction; and (viii) defective cardiac contractility. Preclinical data suggest that there is merit in targeting the identified pathways; however, their clinical implications and outcomes regarding treating HF need further investigation in the future. Herein, we introduce the molecular mechanisms pivotal in the onset and progression of HF, as well as compounds targeting the related mechanisms and their therapeutic potential in preventing or rescuing HF. This, therefore, offers an avenue for the design and discovery of novel therapies for the treatment of HF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureHumansAnimalsAutophagyEndoplasmic Reticulum StressOxidative StressApoptosis

Stichwörter der Autor:innen

apoptosisfibrosisheart failurehypertrophyinflammationmetabolism

Autor:innen und Institutionen

  • Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, UK.

ORCID-Profile: Sanskruti Ravindra Gare

Förderung

  • British Heart Foundation

Zitieren

APA

Fonseka, O., Gare, S. R., Chen, X., Zhang, J., Alatawi, N. H., Ross, C., & Liu, W. (2025). Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential. Cells, 14(5), 324. https://doi.org/10.3390/cells14050324

Vancouver

Fonseka O, Gare SR, Chen X, Zhang J, Alatawi NH, Ross C, et al. Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential. Cells. 2025;14(5):324. doi:10.3390/cells14050324

BibTeX
@article{Fonseka2025,
  author = {Fonseka, Oveena and Gare, Sanskruti Ravindra and Chen, Xinyi and Zhang, Jiayan and Alatawi, Nasser Hawimel and Ross, Claire and Liu, Wei},
  title = {Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {324},
  doi = {10.3390/cells14050324}
}
Kostenlos starten →